Scientific reports

PloS one

progress in neuro-psychopharmacology & biological psychiatry

Langmuir : the ACS journal of surfaces and colloids

Frontiers in psychology

Environmental science & technology

The Journal of pharmacy and pharmacology

current pharmaceutical design

international immunopharmacology

toxicology letters

neuroscience letters

cellular and molecular neurobiology

Biomolecules

Brain

molecular neurobiology

microvascular research

american journal of obstetrics and gynecology

frontiers in molecular neuroscience

neuron

journal of neuroimmunology

environmental toxicology

Neural regeneration research

Journal of neuroinflammation

the neuroscientist : a review journal bringing neurobiology, neurology and psychiatry

current opinion in immunology

Frontiers in bioscience (Landmark edition)

pharmacology & therapeutics

cancer treatment and research communications

[1] Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation.

[2] Time to test antibacterial therapy in Alzheimer's disease.

[3] NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral hemorrhage in mice.

[4] Corrigendum: NEK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury.

[5] Clofibrate, a PPAR-α agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba-1/anti-calbindin signaling pathways.

[6] Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation.

[7] Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.

[8] Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

[9] Pathophysiological Features of Obesity and Its Impact on Cognition: Exercise Training as a Non-Pharmacological Approach.

[10] Eating Disorders: An Evolutionary Psychoneuroimmunological Approach.

[11] Glial cells in intracerebral transplantation for Parkinson's disease.

[12] Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders.

[13] Communication, Cross Talk, and Signal Integration in the Adult Hippocampal Neurogenic Niche.

[14] Dietary Linoleic Acid Lowering Reduces Lipopolysaccharide-Induced Increase in Brain Arachidonic Acid Metabolism.

[15] Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease.

[16] Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner.

[17] Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway.

[18] Effects of RO27-3225 on neurogenesis, PDGFRβ cells and neuroinflammation after cerebral infarction.

[19] Innate sensing of mechanical properties of brain tissue by microglia.

[20] Riluzole improves functional recovery after acute spinal cord injury in rats and may be associated with changes in spinal microglia/macrophages polarization.

[21] Fast Evolution of Sulfuric Acid Aerosol Activated by External Fields for Enhanced Emission Control.

[22] Effects of vaccination on acute-phase protein response in broiler chicken.

[23] Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia.

[24] Oxidative stress in the choroid plexus contributes to blood-cerebrospinal fluid barrier disruption during sepsis development.

[25] A c-Src Inhibitor Peptide Based on Connexin43 Exerts Neuroprotective Effects through the Inhibition of Glial Hemichannel Activity.

[26] Determination of extracellular matrix collagen fibril architectures and pathological remodeling by polarization dependent second harmonic microscopy.

[27] Relationship between inflammatory biomarker galectin-3 and hippocampal volume in a community study.

[28] behavior of neutrophil granulocytes during toxoplasma gondii infection in the central nervous system

[29] arginine is neuroprotective through suppressing hif-1α/ldha-mediated inflammatory response after cerebral ischemia/reperfusion injury

[30] neuroinflammation and behaviour

[31] highly selective cyclooxygenase-1 inhibitors p6 and mofezolac counteract inflammatory state both in vitro and in vivo models of neuroinflammation

[32] subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease

[33] neuroinflammation and j2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration

[34] role of hormones and neurosteroids in epileptogenesis

[35] delirium – biomarkers and genetic variance

[36] curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia

[37] trabalho de consenso de força-tarefa da wfsbp sobre marcadores biológicos das demências: contribuição da análise do lcr e do sangue para o diagnóstico precoce e diferencial das demências consensus paper of the wfsbp task force on biological markers of dementia: the role of csf and blood analysis in the early and differential diagnosis of dementia (world j biol psychiatry. 2005;6(2):69-84. review)

[38] editorial: the metabolic-inflammatory axis in brain aging and neurodegeneration

[39] multi-target anti-alzheimer activities of four prenylated compounds from psoralea fructus

[40] neuroimmunology of the interleukins 13 and 4

[41] intracisternal delivery of nfkappab-inducible scaav2/9 reveals locoregional neuroinflammation induced by systemic kainic acid treatment.

[42] new multiple sclerosis disease severity scale predicts future accumulation of disability

[43] curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of alzheimer’s disease

[44] methamphetamine effects on blood-brain barrier structure and function

[45] implications of glial nitric oxyde in neurodegenerative diseases

[46] differentiation and transmigration of cd4 t cells in neuroinflammation and autoimmunity

[47] myeloid extracellular vesicles: messengers from the demented brain

[48] bee venom acupuncture reduces interleukin-6, increases interleukin-10, and induces locomotor recovery in a model of spinal cord compression

[49] monosodium urate crystals activate the inflammasome in primary progressive multiple sclerosis

[50] editorial: microglial polarization in the pathogenesis and therapeutics of neurodegenerative diseases

[51] neurovascular unit dysfunction and blood–brain barrier hyperpermeability contribute to schizophrenia neurobiology: a theoretical integration of clinical and experimental evidence

[52] ginkgo biloba extract inhibits astrocytic lipocalin-2 expression and alleviates neuroinflammatory injury via the jak2/stat3 pathway after ischemic brain stroke

[53] stress-induced neuroinflammatory priming: a liability factor in the etiology of psychiatric disorders

[54] understanding the neuroinflammatory response following concussion to develop treatment strategies

[55] the anti-inflammatory effects of lipoxygenase and cyclo-oxygenase inhibitors in inflammation-induced human fetal glia cells and the aβ degradation capacity of human fetal astrocytes in an ex vivo assay

[56] neuroinflammation, bone marrow stem cells, and chronic pain

[57] unique contribution of haptoglobin and haptoglobin genotype in aneurysmal subarachnoid hemorrhage

[58] forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia

[59] histone deacetylase inhibitor alleviates the neurodegenerative phenotypes and histone dysregulation in presenilins-deficient mice

[60] comment on successful therapies for alzheimer’s disease: why so many in animal models and none in humans?

[61] cellular and molecular mechanisms of motor neuron death in amyotrophic lateral sclerosis: a perspective

[62] microglial activation in traumatic brain injury

[63] Lipopolysaccharide Pre-conditioning Attenuates Pro-inflammatory Responses and Promotes Cytoprotective Effect in Differentiated PC12 Cell Lines via Pre-activation of Toll-Like Receptor-4 Signaling Pathway Leading to the Inhibition of Caspase-3/Nuclear Factor-κappa B Pathway

[64] Schisandrin B restores M1/M2 balance through miR-124 in lipopolysaccharide-induced BV2 cells.

[65] The Impact of Surface Modifier on Magnetic Nanoparticle Properties and Their Application in CD3+T Cell Separation.

[66] The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro.

[67] VSIG4 Alleviates Intracranial Hemorrhage Injury by Regulating Oxidative Stress and Neuroinflammation in Macrophages via the NRF2/HO-1 Signaling Pathway.

[68] The roles of Flavonoles/Flavonoids in Neurodegeneration and Neuroinflammation.

[69] The role of TLR4 and HO-1 in neuroinflammation after subarachnoid hemorrhage.

[70] The Legacy of Rita Levi-Montalcini: From Nerve Growth Factor to Neuroinflammation.

[71] Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy

[72] Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation.

[73] Neuroinflammation and Neuromodulation in Neurological Diseases.

[74] Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase.

[75] Potential biomarkers for neuroinflammation and neurodegeneration at short and long term after neonatal hypoxic-ischemic insult in rat.

[76] NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral hemorrhage in mice.

[77] Corrigendum: NEK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury.

[78] Novel potential pyrazolopyrimidine based translocator protein ligands for the evaluation of neuroinflammation with PET

[79] Clofibrate, a PPAR-α agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba-1/anti-calbindin signaling pathways.

[80] Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation.

[81] Exosomes as mediators of neuron-glia communication in neuroinflammation

[82] Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway.

[83] Effects of RO27-3225 on neurogenesis, PDGFRβ cells and neuroinflammation after cerebral infarction.

[84] Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation.

[85] Shifting equilibriums in Alzheimer's disease: The complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis

[86] CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells

[87] Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia.

[88] Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases

[89] Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation.

[90] Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease

[91] phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition

[92] pyrrolidine dithiocarbamate prevents neuroinflammation and cognitive dysfunction after endotoxemia in rats

[93] neuroinflammation and behaviour

[94] highly selective cyclooxygenase-1 inhibitors p6 and mofezolac counteract inflammatory state both in vitro and in vivo models of neuroinflammation

[95] therapeutically targeting neuroinflammation and microglia after acute ischemic stroke

[96] puerarin alleviates neuropathic pain by inhibiting neuroinflammation in spinal cord

[97] subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease

[98] neuroinflammation and j2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration

[99] magnetic resonance imaging of glutamate in neuroinflammation

[100] inflammasomes in neuroinflammation and changes in brain function: a focused review

[101] cellular and molecular mediators of neuroinflammation in the pathogenesis of parkinson’s disease